AVBP - CIK 0001868279
ArriVent BioPharma, Inc. has filed 144 documents with the SEC between 2021 and 2026. The most frequent type is insider trade (26 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2025-05-12 | 2025-05-12 |
| Insider trade | 4 | 2025-04-29 | 2025-04-28 |
| New insider ownership | 3 | 2025-04-29 | 2025-04-28 |
| Annual report to shareholders | ARS | 2025-04-28 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-28 | - |
| Proxy statement | DEF 14A | 2025-04-28 | 2025-06-18 |
| Major company event | 8-K | 2025-04-28 | 2025-04-23 |
| Major company event | 8-K | 2025-03-13 | 2025-03-11 |
| Major company event | 8-K | 2025-03-03 | 2025-03-03 |
| Annual report | 10-K | 2025-03-03 | 2024-12-31 |
| Employee stock plan | S-8 | 2025-03-03 | - |
| Insider trade | 4 | 2025-02-14 | 2025-02-03 |
| Insider trade | 4 | 2025-02-14 | 2025-02-03 |
| Insider trade | 4 | 2025-02-14 | 2025-02-03 |
| Insider trade | 4 | 2025-02-14 | 2025-02-03 |
| Insider trade | 4 | 2025-02-14 | 2025-02-03 |
| SCHEDULE 13G | - | 2025-02-14 | - |
| S-3ASR | - | 2025-02-03 | - |
| Major company event | 8-K | 2025-01-22 | 2025-01-21 |
| Passive ownership stake | SC 13G | 2024-12-04 | - |
| Quarterly report | 10-Q | 2024-11-14 | 2024-09-30 |
| Major company event | 8-K | 2024-11-14 | 2024-11-14 |
| Passive ownership stake | SC 13G | 2024-11-14 | - |
| Passive ownership stake | SC 13G | 2024-11-12 | - |
| Passive ownership stake | SC 13G | 2024-11-12 | - |
| Passive ownership stake | SC 13G | 2024-11-08 | - |
| Passive ownership stake | SC 13G | 2024-10-24 | - |
| Passive ownership stake | SC 13G | 2024-10-11 | - |
| Insider trade | 4 | 2024-09-23 | 2024-09-19 |
| Major company event | 8-K | 2024-09-09 | 2024-09-09 |
| Quarterly report | 10-Q | 2024-08-14 | 2024-06-30 |
| Major company event | 8-K | 2024-08-14 | 2024-08-14 |
| Major company event (amended) | 8-K/A | 2024-07-09 | 2024-05-16 |
| Major company event (amended) | 8-K/A | 2024-07-09 | 2024-04-20 |
| Major company event | 8-K | 2024-06-05 | 2024-06-04 |
| Insider trade | 4 | 2024-05-20 | 2024-05-16 |
| New insider ownership | 3 | 2024-05-20 | 2024-05-16 |
| Major company event | 8-K | 2024-05-16 | 2024-05-16 |
| Quarterly report | 10-Q | 2024-05-08 | 2024-03-31 |
| Major company event | 8-K | 2024-05-08 | 2024-05-08 |
| Insider trade | 4 | 2024-04-23 | 2024-04-22 |
| New insider ownership | 3 | 2024-04-23 | 2024-04-20 |
| Major company event | 8-K | 2024-04-22 | 2024-04-20 |
| Annual report | 10-K | 2024-03-28 | 2023-12-31 |
| Major company event | 8-K | 2024-03-28 | 2024-03-28 |
| Passive ownership stake | SC 13G | 2024-02-13 | - |
| Activist ownership stake | SC 13D | 2024-02-05 | - |
| Employee stock plan | S-8 | 2024-02-02 | - |
| Insider trade | 4 | 2024-02-01 | 2024-01-30 |
| Insider trade | 4 | 2024-01-31 | 2024-01-30 |